This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Genome Research Limited. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Sandro Morganella: Innovator in DNA Characterization
Introduction
Sandro Morganella is a prominent inventor based in Hinxton, GB. He has made significant contributions to the field of genetic research, particularly in the characterization of DNA samples obtained from tumors. His work has implications for cancer treatment and personalized medicine.
Latest Patents
Sandro Morganella holds 2 patents that focus on methods for characterizing DNA samples. His first patent, titled "Method of characterising a DNA sample," outlines a process for determining the presence or absence of various genetic signatures in tumor samples. This method generates a probabilistic score to identify whether a sample is homologous recombination (HR)-deficient, which can inform treatment choices such as the use of PARP inhibitors or platinum therapy. His second patent, also titled "Method of characterizing a DNA sample," provides a comprehensive approach to producing an interpreted profile of tumors based on a range of tests, including the identification of base substitution signatures, rearrangement signatures, and putative driver mutations.
Career Highlights
Sandro Morganella is associated with Genome Research Limited, where he applies his expertise in genetic research. His innovative methods have the potential to enhance the understanding of tumor biology and improve treatment strategies for cancer patients.
Collaborations
Sandro has collaborated with notable colleagues, including Serena Nik-zainal and Helen Davies, who share his commitment to advancing cancer research.
Conclusion
Sandro Morganella's contributions to DNA characterization represent a significant advancement in the field of oncology. His innovative patents and collaborative efforts continue to pave the way for improved cancer treatment options.